These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Antiarrhythmic effects of magnesium sulphate. Report of three cases. Knudsen K; Abrahamsson J Acta Anaesthesiol Scand; 1995 Aug; 39(6):850-4. PubMed ID: 7484048 [TBL] [Abstract][Full Text] [Related]
28. Images in clinical medicine. Digoxin-induced bidirectional ventricular tachycardia. Valent S; Kelly P N Engl J Med; 1997 Feb; 336(8):550. PubMed ID: 9023092 [No Abstract] [Full Text] [Related]
29. Muscle magnesium content and cardiac arrhythmias during treatment of congestive heart failure due to chronic chagasic cardiomyopathy. Câmara EJ; Cruz TR; Nassri JM; Rodrigues LE Braz J Med Biol Res; 1986; 19(1):49-58. PubMed ID: 3801726 [TBL] [Abstract][Full Text] [Related]
30. The role of magnesium in digitalis--induced arrhythmias. Govil MK; Agrawal BD; Gupta BK; Sur BK; Mathur PK J Assoc Physicians India; 1979 Dec; 27(12):1059-65. PubMed ID: 549914 [No Abstract] [Full Text] [Related]
31. Magnesium treatment of torsade de pointes--a case report. Gould LA; Betzu R; Vacek T; Muller RT; Pradeep V; Scafa A Angiology; 1990 Jul; 41(7):577-81. PubMed ID: 2389840 [TBL] [Abstract][Full Text] [Related]
32. Intravenous magnesium sulfate for acute termination of sustained monomorphic ventricular tachycardia associated with coronary artery disease. Farouque HM; Sanders P; Young GD Am J Cardiol; 2000 Dec; 86(11):1270-2, A9. PubMed ID: 11090808 [TBL] [Abstract][Full Text] [Related]
33. Hypermagnesuria in Humans Following Acute Intravenous Administration of Digoxin. Abu-Amer N; Priel E; Karlish SJD; Farfel Z; Mayan H Nephron; 2018; 138(2):113-118. PubMed ID: 29169235 [TBL] [Abstract][Full Text] [Related]
34. Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential. Satoh Y; Sugiyama A; Tamura K; Hashimoto K Jpn Circ J; 2000 Jun; 64(6):445-51. PubMed ID: 10875735 [TBL] [Abstract][Full Text] [Related]
35. Hypomagnesemia and magnesium sulphate therapy in digoxin intoxication. Singh RB; Srivastav DK; Mohan M; Dube KP; Katiyar BC J Assoc Physicians India; 1975 Jun; 23(6):367-72. PubMed ID: 1184562 [No Abstract] [Full Text] [Related]
36. [Antiarrhythmic effects of intravenous magnesium sulfate in torsade de pointes. Apropos of 6 cases]. Etienne Y; Blanc JJ; Songy B; Boschat J; Guiserix J; Etienne E; Egreteau JP; Penther P Arch Mal Coeur Vaiss; 1986 Mar; 79(3):362-7. PubMed ID: 3087320 [TBL] [Abstract][Full Text] [Related]
37. [Relationship between digoxin-induced cardiac arrhythmias and serum-digoxin levels (author's transl)]. Hennersdorf G; Mariss P; Biermann S; Haindl H; Lichtlen P Dtsch Med Wochenschr; 1977 Mar; 102(11):381-4. PubMed ID: 66122 [TBL] [Abstract][Full Text] [Related]
38. Recrudescent digoxin toxicity treated with plasma exchange: a case report and review of literature. Rajpal S; Beedupalli J; Reddy P Cardiovasc Toxicol; 2012 Dec; 12(4):363-8. PubMed ID: 22618329 [TBL] [Abstract][Full Text] [Related]
39. Magnesium and cardiovascular drugs: interactions and therapeutic role. Crippa G; Sverzellati E; Giorgi-Pierfranceschi M; Carrara GC Ann Ital Med Int; 1999; 14(1):40-5. PubMed ID: 10528423 [TBL] [Abstract][Full Text] [Related]
40. Intravenous magnesium for cardiac arrhythmias: jack of all trades. Ho KM Magnes Res; 2008 Mar; 21(1):65-8. PubMed ID: 18557136 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]